Proteins were extracted using 1X RIPA buffer supplemented with protease/phosphatase inhibitor cocktail (Thermo Fisher Scientific Inc., Waltham, MA), and concentration determined using the BCA protein assay kit (Thermo Fisher Scientific Inc., Waltham, MA). Immunoblots (western blot) were performed as previously described [48 (link)]. Primary antibodies against ERK1/2, p-ERK1/2 (Thr202/Tyr204), MEK1/2, p-MEK1/2 (Ser217/221), p-PKCα/β II (Thr638/641), CAMKII, p-CAMKII (Thr286), BIM; p-BIM (Ser69), CHOP, Bcl-2, Bcl-xL, p-eIF2α (Ser51), STIM1, PARP, NEDD8 and secondary HRP-conjugated antibodies were obtained from Cell Signaling (Danvers, MA). Antibodies for PKCβ, luciferase, ERO1 and Orai1 were purchased from Santa Cruz Biotechnology (Dallas, TX). Proteins expression was determined by densitometry analysis of the immune-detected bands, normalized to β-actin, and presented relative to control (fold induction). Co-IP assays were carried out using the Pierce™ Classic Magnetic IP Kit (Thermo Fisher Scientific Inc., Waltham, MA) as described [49 (link)].
Free full text: Click here